2021
DOI: 10.1101/2021.10.17.464666
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Neurexins Regulate GABA Co-release by Dopamine Neurons

Abstract: Midbrain dopamine (DA) neurons are key regulators of basal ganglia functions. The axonal domain of these neurons is highly complex, with a large subset of non-synaptic release sites and a smaller subset of synaptic terminals from which glutamate or GABA are released. The molecular mechanisms regulating the connectivity of DA neurons and their neurochemical identity are unknown. Here we tested the hypothesis that the trans-synaptic cell adhesion molecules neurexins (Nrxns) regulate DA neuron neurotransmission. … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3
1

Relationship

3
1

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 54 publications
(123 reference statements)
0
6
0
Order By: Relevance
“…In another study, the pan-Nrxn cKO approach in DA neurons reduced amphetamineinduced locomotor activity without affecting other striatal-dependent behaviors such as motor coordination or sucrose preference. This investigation suggests that DAT-IRES-Cre driven deletion of neurexin genes can impair DAT function (expressed on DA neurons) leading to altered behavioral responses to DA-acting drugs (Ducrot et al, 2021).…”
Section: Nrxn1αβ Nrxn2αβ and Nrxn3αβmentioning
confidence: 86%
See 3 more Smart Citations
“…In another study, the pan-Nrxn cKO approach in DA neurons reduced amphetamineinduced locomotor activity without affecting other striatal-dependent behaviors such as motor coordination or sucrose preference. This investigation suggests that DAT-IRES-Cre driven deletion of neurexin genes can impair DAT function (expressed on DA neurons) leading to altered behavioral responses to DA-acting drugs (Ducrot et al, 2021).…”
Section: Nrxn1αβ Nrxn2αβ and Nrxn3αβmentioning
confidence: 86%
“…The study employed a pan-Nrxn cKO approach in four central synapses: excitatory Calyx of Held synapses in the brainstem, excitatory and inhibitory synapses in pyramidal neurons in the CA1 region of the hippocampus, and inhibitory basket cell synapses in the cerebellum, thus showing that neurexins universally regulate presynaptic GABA B -receptor signaling, albeit at different magnitude between synapses (Luo et al, 2021). More recent work shows that neurexins regulate GABA co-release in dopamine (DA) neurons (Ducrot et al, 2021). The pan-Nrxn cKO approach in DA neurons, showed (1) region-specific increase in GABA release from DA terminals (increase in the ventral but not in the dorsal striatum) and (2) slower DA reuptake along with decreased and increased densities of DA transporter (DAT) and vesicular monoamine transporter (VMAT2), respectively (Ducrot et al, 2021), indicating that neurexins support the functional but not the structural aspect of DA neuron synapses.…”
Section: Nrxn1αβ Nrxn2αβ and Nrxn3αβmentioning
confidence: 99%
See 2 more Smart Citations
“…Segregation of DA and glutamate within dopaminergic axonal terminals has been found to be induced by contact with ventral striatal neurons ( Fortin et al, 2019 ), which may underlie the differences in release and recycling properties of DA and glutamate ( Silm et al, 2019 ). Neurexins have recently been identified as key trans-synaptic regulators of DA transmission that also influence GABA co-transmission ( Ducrot et al, 2021 ). Several cytoskeletal proteins associate with D2 receptors, including actin binding proteins and spinophilin to control surface expression of receptors, maintain their density, and regulate receptor signaling ( Li et al, 2000 ; Smith et al, 1999 ).…”
Section: Discussionmentioning
confidence: 99%